MSB 0.91% $1.11 mesoblast limited

Cell Therapy News/Articles, page-6292

  1. 944 Posts.
    lightbulb Created with Sketch. 299
    It's not Mesoblast's trial, it's Cynata.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.